Class C IVDs — companion diagnostics, cancer screening, genetic tests — face the May 2026 IVDR deadline. Are you ready?
Read MoreThe Commission's proposal COM(2025) 1023 to amend the MDR and IVDR: what it changes and what it means for manufacturers.
Read MoreThe EU has extended transition periods for legacy IVDs. The new dates, the conditions, and what to do to keep market access.
Read MoreMDCG 2024-11 clarifies when a product qualifies as an IVD under the IVDR. The key points.
Read MoreThe European Parliament's push to overhaul the MDR and IVDR: what is on the table and why.
Read MoreWhere the MDR, IVDR and UK MDR transition deadlines stand after the extensions, and what still applies.
Read MoreThe Commission's 2021 proposal for a progressive IVDR rollout gave the industry more time. What it meant.
Read More